USA flag logo/image

An Official Website of the United States Government

Ocular Scanning Instrumentation Diagnosis of Induced Trauma from Thermobaric…

Award Information

Agency:
Department of Defense
Branch:
Army
Award ID:
68088
Program Year/Program:
2004 / SBIR
Agency Tracking Number:
03SB2-0104
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
MD BIOTECH, INC.
511 Burrough St. Morgantown, WV 26505
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2004
Title: Ocular Scanning Instrumentation Diagnosis of Induced Trauma from Thermobaric Weapon Detonation
Agency / Branch: DOD / ARMY
Contract: W911NF-04-C-0033
Award Amount: $96,973.00
 

Abstract:

US military warfighters are in critical need of technologies/equipment which provide expedient, reliable and non-invasive diagnostic capabilities to aid in the evaluation and treatment of battlefield trauma. By providing quick and accurate diagnosis of the type and extent of trauma, such equipment would allow warfighters to more rapidly assess and implement the most effective course of action. Of particular concern are soldiers exposed to thermobaric blasts or other factors that may cause internal trauma within the theater of operation. Early diagnosis of internal trauma induced by a primary blast wave via a field-deployable, rapid, and non-invasive technique will provide an invaluable tool in the subsequent success of treating such conditions. The current Phase I proposal seeks to establish and validate the feasibility of using ocular biomarkers for the diagnosis/detection of specific, unapparent internal traumas resulting from overpressure exposure. Eventually, algorithms which quantitatively evaluate the determined biomarkers may be incorporated into our Ocular Scanning Instrumentation (OSI) technology. The OSI technology has thus far been developed around the capability of diagnosing exposure to chemical and biological threat agents. The resulting system will serve as an early-diagnostic system for theater of operation casualty assessment based upon generalized information obtained from ocular biomarkers.

Principal Investigator:

Lance Molnar
Dir. Life Sciences Resear
3045981101
lmolnar@mdbiotechinc.com

Business Contact:

Christopher Kolanko
President, Chief Scientif
3045981101
chriskolanko@mdbiotechinc.com
Small Business Information at Submission:

MD BIOTECH, INC.
511 Burrough St. Morgantown, WV 26505

EIN/Tax ID: 559783078
DUNS: N/A
Number of Employees:
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No